Abstract
Introduction

26
Type 2 diabetes (T2D) is a complex disease characterized by impaired glucose homeostasis resulting from 27 dysfunction in insulin-secreting pancreatic islets and decreased insulin sensitivity in peripheral tissues 28 [1] . In addition to environmental factors such as a sedentary lifestyle and poor diet, genetic susceptibility 29 is an important contributor to the development of T2D [2] . Genome-wide association studies (GWAS) 30 have uncovered more than 100 loci that significantly associate with either T2D or glucose-related traits
31
[3, 4, 2]. However, the majority of single nucleotide polymorphisms (SNPs) significantly associated with 32 T2D reside in intronic and intergenic regions rather than protein-encoding regions [5, 6] . The results from
33
GWAS suggest an important role for genetic variation that regulates gene expression rather than altering 34 codon sequence [7] and have motivated e↵orts to map the regulatory landscape of the genome [8, 9, 10].
35
Indeed, sets of trait-associated SNPs are enriched for variants that associate with gene expression (i.e.
36
expression quantitative trait loci or eQTLs) [11] and that occupy DNAse hypersensitivity sites (DHS) [ Table 1 . Significant association between predicted expression and T2D. Bonferroni corrected for all gene tissue pairs tested. When multiple tissues were significant, the top tissue result is shown.
Significant genes enriched in relevant pathways
112
To glean insight into relevant biological pathways, we performed a gene set enrichment analysis on the set 113 of FDR  0.05 significant genes and found top Gene Ontology Biological Process (GO:BP) pathways to 114 involve the insulin-secretory pancreatic -cell (e.g. negative regulation of type B pancreatic cell apoptotic 115 process, Supplemental Figure S4 ). This was also the case when we restricted this analysis to the set of 116 reported T2D genes (Supplemental Table S5 ). However, we found fatty acid homeostasis to be a top 117 pathway enriched among the set of novel T2D genes implicated in our MetaXcan analysis, underscoring 118 a genetic contribution from variants regulating gene expression in insulin-responsive peripheral tissues
119
(Supplemental Table S6 ).
120
Enrichment of genes reported for related traits
121
We also explored shared etiology with other complex diseases by comparing our set of MetaXcan-122 implicated T2D genes with sets of genes implicated by GWAS listed in the NHGRI-EBI online catalogue.
123
Unsurprisingly, we found that the set of MetaXcan-significant genes nearest to associated SNPs from the 124 trans-ethnic study (i.e. reported T2D genes) were enriched among gene sets annotated to type 2 diabetes
125
(p = 0.0001), fasting glucose-related traits with BMI interaction (p = 0.001), two-hour glucose challenge 6 (p = 0.007), and glycated hemoglobin levels (p = 0.028) (Supplementary Table S7 ). However, an analysis 127 based on the set of novel T2D genes (i.e. genes distal to associated SNPs from the trans-ethnic study 128 at p < 5 ⇥ 10 6 ) revealed an enrichment for epilepsy (p = 0.0001) attributable to novel genes COPZ2,
129
SNX11, and MAST4 (Supplementary Table S8 ). Similarly, novel T2D genes CCDC92, HOXA11, MEIS1,
130
and JUND were responsible for an observed enrichment for BMI-adjusted waist-to-hip ratio (p = 0.0004).
131
HKDC1 is a novel T2D gene implicated by our MetaXcan analysis that has been previously implicated 132 in pregnancy-related glycemic traits and is the driver of the observed enrichment for this phenotype
133
(p = 0.044) (Supplemental Table S8 ).
134
Replication of novel T2D genes in independent GERA study 
142
Of the 90 top genes chosen for replication (discovery FDR < 0.05), 34 replicated (p < 0.05); 13
143
were previously reported genes, 15 were novel genes in known loci, and 6 were novel genes in novel loci.
144
Moreover, the direction of e↵ect was consistent across replicated associations (Figure 2 ).
145
Interestingly, decreased expression of HKDC1 in aortic artery (p = 0.024) replicated in GERA.
146
We observed replication for increased expression of C2 in subcutaneous adipose tissue (p = 4.9 ⇥ 10 4 ),
147
HOXA11 in sigmoid colon (p = 0.0016), and CYP21A2 in visceral (omentum) adipose tissue (p = 0.046).
148
The remaining set of novel genes replicated at regions spanning T2D-associated loci (i.e. T2D windows)
149
include EVC, ID4, EXT1, NUDT5, CYP26C1, DCLRE1A, GPAM, NHLRC2, RCN2, and CTD-2021H9.3
150
(Supplementary Table S9) .
151
Among reported genes that replicated in GERA are JAZF1, HHEX, WFS1, CAMK1D, NCR3LG1,
152
AP3S2, HMG20A, CDKN2A, KCNJ11, IRS1, and IGF2BP2 (Table S1) 153
Five genes outside of known T2D regions replicated in GERA. These include KCNK17 (potassium 154 two pore domain channel subfamily K member 17), two zinc finger protein encoding genes, ZNF703 (zinc of the expression levels of the same genes increase the risk of a later-onset T2D. B. Significance of top T2D-associated genes across tissues. Z-scores of the association between predicted expression levels and T2D case control status across 44 human tissues is shown. Except for RCCD1, CWF19L1, and AP3S2, genes are associated in only a few tissues indicating context specificity. The size of the circles represent the magnitude of the Z-score. Blue color represents positive association, i.e. increase in expression level associated with increase in T2D risk. Red color represents negative association. The intensity of the color represents the performance of the prediction models (correlation squared between predicted and observed expression levels cross-validated in the training samples). Therefore larger circles indicate more significant associations whereas darker colors indicate higher prediction confidence. Missing circles mean that the association was not performed because of missing model (no good prediction model) or because the prediction SNPs were absent in the GWAS. . Green circles correspond to a subset of the monogenic gene list, considered to cause diabetes as the main phenotype. We see that monogenic genes are enriched in significant genes (away from the gray line) and that the subset where the phenotype is diabetes is even more enriched (further away from the gray identity line). OMIM (gray +) and ClinVar (red +) list yield similar enrichments. p-values below 10 10 have been capped to 10 10 for better visualization.
MetaXcan provides a principled way to prioritize e↵ector genes in known trait-associated loci. To imple-198 ment this, we defined 68 non-overlapping windows comprising known T2D-associated SNPs (see details
199
in Methods) which we refer to as T2D-loci. We profiled these loci according to the strength, number,
200
and proximity of predicted gene expression associations. We used two thresholds for the multiple test accounts for the total number of tests within the locus (locus-wide p threshold varies by locus).
204
We found that 33 loci had at least one locus-wide significant association (Supplementary Table S9 ). Table S9 ). We next highlight a few loci of interest.
210
JAZF1 locus
211
At the window comprising T2D-associated SNPs at the JAZF1 locus, we observed multiple tissue-level 212 associations for JAZF1, the reported T2D gene in this region. Decreased expression of JAZF1 in multiple 213 tissues (inlcuding skeletal muscle, adipose, and pancreas) was associated with T2D (Table S1 and Figure   214 5A). In addition to JAZF1, we find that increased expression of HOXA11, an upstream transcription 215 factor-encoding gene, is associated with T2D at the locus-wide level ( Figure 5A ).
216
To gain further insight into these associations, we examined the e↵ect of the SNPs that make up the 217 prediction models on the phenotype and on the expression of the corresponding gene. We find that many 218 of the SNPs in the prediction models for JAZF1 fall within eQTL association peaks in these tissues and
219
are themselves significantly associated with T2D ( Figure 5B-C) . Moreover, the disease-promoting alleles The reported gene, CDKAL1, showed no significant association whereas predicted gene expression of 225 nearby genes ID4 and SOX4 associated with T2D ( Figure 5E ). Although there were multiple eQTL 226 association peaks evident among the set of SNPs in the prediction models for these genes, there was only 227 one GWAS peak in this region. Moreover, the disease-promoting alleles of the model SNPs within the 228 shared peak associated with a decrease in gene expression 5F-G.
229
AP3S2, PRC1, and VPS33B locus
230
We observed the most tissue-level gene associations at a region spanning three reported T2D genes:
231
AP3S2, PRC1, and VPS33B ( Figure 6A ). Although each of these putative T2D genes were supported 232 by our MetaXcan analysis, the most significant associations at this region corresponded to a novel T2D 233 gene, RCCD1, with increased expression of this gene associated with T2D( Figure 6A , Table S1 , and
234
Supplementary Table S9) .
235
The only other gene in this interval supported by at least one genome-wide significant association was 236 the reported T2D gene AP3S2 where increased expression was associated with disease status. Moreover,
237
increased expression of AP3S2 in 29 tissue models associated with T2D at the window-level threshold
238
( Figure 6A and Supplementary Table S9 ).
239
The variants underlying the top associations for RCCD1 and AP3S2 are independent from each Figure 6A-B) . The predictive models underlying these associations share three We performed a large-scale, in silico study of predicted gene expression across a comprehensive set of 267 human tissues to prioritize genes that alter the risk of T2D through regulation of gene expression levels.
268
We corroborated many of the known T2D genes, which supports the role of regulation of gene expression 269 levels as a key mediating mechanism, but also found novel genes both in known loci as well as in completely 270 novel loci. Replication in an independent cohort gives further support to our results. 
281
Averaging across the genome, we found that diabetes relevant tissues such as liver, pancreas, adipose,
282
and muscle are enriched with significant associations. However, when we look into individual genes 283 at the top significance level we found associations in tissues that are not typically linked to diabetes.
284
For example, TCF7L2 was significantly associated only in aortic artery and adrenal gland, which is a 285 consequence of the fact that with GTEx samples active regulation of this gene was only found in these 286 tissues.
287
Most associations were discovered in a few tissues indicating strong context specificity. genome-wide significant associations at some regions encompassing putative T2D genes.
298
The predictive models employed in this study were trained from local variants within 
305
In our study, we applied MetaXcan to explicitly integrate regulatory genetic information to improve 306 disease gene mapping and overcome key limitations of GWAS and di↵erential gene expression studies [21] . 3) reference panel [37] with ShapeIt2 [38] . The full set of ⇠1. 
346
The SNP coe cients from this procedure are used as weights to estimate the genetic component of gene 347 expression and are publicly available (http://predictdb.org).
Trans-ethnic Study summary data. Input GWAS summary data used in our MetaXcan-based as- 
where w l,g represents the prediction model weight for SNP l on gene g, l is the standard deviation for 392 SNP l,ˆ g is the standard deviation of predicted expression for gene g,ˆ l is the regression coe cient for 393 the regression of expression on the allelic dosage of SNP l.
394
In our MetaXcan analyses of T2D, we use regression coe cients (ˆ l ) from results from the trans-ethnic 395 meta-analysis of GWAS and the GWAS on T2D from the GERA study. Values for w l,g were generated
396
as described above and available from the PredictDB website (http://predictdb.org).ˆ 2 g is estimated 397
as:
X g . We use SNP information from a 1000 Genome Project reference panel (European ancestry) to the 400 compute the variances and covariances of the SNPs used to predict gene expression.
401
Locus analysis of T2D-associated regions
402
We first identified a set of 111 reported T2D genes based on their being the most proximal to T2D- analyses of the trans-ethnic and GERA studies where the Z-score (Z) was given by:
where Z i = 1 (P i /2) ⇤ sign( i ), P i is the p-value for study i, w i = p (N i ), N i refers to the sample size 420 for study i, i is the direction of e↵ect in study i, and the overall P-value is given by: 
